Chu, David
Park, Ben Ho
Funding for this research was provided by:
National Institutes of Health (P30 CA006973)
Article History
Received: 14 December 2016
Revised: 20 April 2017
Accepted: 26 April 2017
First Online: 2 May 2017
Compliance with ethical standards
:
: B.H.P. is a member of the scientific advisory boards of Horizon Discovery, LTD, and Loxo Oncology, has ownership interest in Loxo Oncology, and has research contracts with Genomic Health, Inc. and Foundation Medicine, Inc. Under separate licensing agreements between Horizon Discovery, LTD, and The Johns Hopkins University, B.H.P. is entitled to a share of royalties received by the University on sales of products. The terms of this arrangement are being managed by the Johns Hopkins University, in accordance with its conflict of interest policies. D.C declares no potential conflicts.